|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/545 | |
| G01N 33/50 | |||
| C12N 5/074 | |||
| A61K 38/19 | |||
| A61K 38/20 | |||
| A61P 9/00 |
| (11) | Patento numeris | 2539439 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11747958.4 |
| Europos patento paraiškos padavimo data | 2011-02-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/025846 |
| Data | 2011-02-23 |
| (87) | Numeris | WO 2011/106365 |
| Data | 2011-09-01 |
| (30) | Numeris | Data | Šalis |
| 308103 P | 2010-02-25 | US |
| (72) |
WODA, Juliana, Megan, US
TING, Anthony, E., US
LEHMAN, Nicholas, A., US
|
| (73) |
ABT Holding Company,
3201 Carnegie Avenue, Cleveland, OH 44115,
US
|
| (54) | MODULATION OF ANGIOGENESIS |
| MODULATION OF ANGIOGENESIS |